Drug giant Novartis says it will give its Cambridge neighbor, MIT, $65 million over 10 years to create a research program, likely to be the biggest in the world aimed at revolutionizing the way drugs are made.
The goal is to help companies move from making drugs in batches to using a continuous high-tech process that will save time and money.
More
2 comments:
Gee that explains where the Novartis bonuses went. Novartis is so badly mismanaged (particularly in the West)that I'm surprised this company is surviving.
Novartis has a promising pipeline but if they keep losing sales reps the way they are and micromanaging them there won't be anyone to sell these new innovative meds!
Post a Comment